Afto Capital

Founder and Managing Partner

Founder and CEO

Pacific Gas and Electric Company

Manager, Gas Workstream Program

Supervisor - Project Management

Synergy Project Management

Project Manager

Kiewit

Engineer

Cleveland Range Ltd.

- Design and implementation of new equipment fixtures.
- Development of operators manual company wide.
- Implement engineering change orders.

Process Engineer

Fenco Automotive Products

- Process analysis and feasibility studies on existing process methods.
- Quality inspection and testing.

Process/Quality Engineer

Real Estate Investor | 🏢 Partnering with accredited investors and busy professionals to buy multifamily apartments

I am a real estate investor focused on acquiring multifamily real estate across the country. I look for cash flowing opportunities that can provide short and long term benefit to our investors. I'm passionate about the power of real estate and how it can give people the opportunity to free up their time to do what they enjoy the most. 🏢

👉  I look for off market properties in strong markets across the US
👉  I underwrite the properties based on the most accurate and realistic business plan for the asset
👉  I assemble the team that's best suited to close and operate the property
👉  Once acquired, I will oversee and ensure the asset is managed smoothly so that investors are seeing the highest benefit from the asset  

📖  I'm all about educating others on benefits of real estate and how it can provide financial freedom/independence. 📖

🔎  Above all, I believe in positive mindset and attitude 
🔎  I pride myself on being transparent in everything I do
🔎  I partner with those that share the same vision, goals and values as me
🔎  Accountability is HUGE in everything I do. I hold myself accountable to the highest standards and also expect the same from everyone around me
🔎  I will help others as best as I can so they can achieve their goals

I will always answer your questions and comments:

📨  sam@aftocapital.com
💻  www.aftocapital.com

➡️  "You miss 100% of the shots you don't take"
➡️  "Luck is when preparation meets opportunity"
➡️  "Don't wait to buy real estate. Buy real estate and wait.
➡️  "Price is what you pay. Value is what you get."

Sam Khairi

Bluejay Therapeutics

Associate Director, Clinical Operations

 BBA Consulting -  Independent Consulting

Deliver robust Clinical Operations & Project Management leadership & expertise for the Pharmaceutical and Biotechnology drug development industry from start-up to close-out. 

Past Clients: 
Zogenix, Jazz Pharma, IGM Bio, Kronos Bio, Ultragenyx.

Senior Clinical Operations Consultant

Golden Gate University

Support the Alumni Association’s governing body with the mission of fostering beneficial connections among alumni, students and faculty

http://www.ggu.edu/alumni/board-of-directors/

GGU Alumni Board of Directors

Private Investor

* Cryptocurrency
* Real Estate Investor (Buy & Hold Multi-Family, Apartment Syndications, Fix & Flip, Self Storage)
* Disruptive/Innovative Stocks

Founder & CEO - BBA Capital Investments

Kronos Bio

Project contributions supported the advancement of Istisociclib (KB-0742 - CDK9 inhibitor) Phase 1/2 clinical trials.

Senior Clinical Trial Manager - Senior Clinical Operations Consultant

Ultragenyx

Project contributions supported the advancement of DTX401 (GSDIa), UX701 (Wilson Disease), and UX143 (OI) Phase 2/3 clinical trials.

IGM Biosciences, Inc.

Project contributions supported the advancement of imvotamab (IGM-2323) Phase 1/2 autoimmune clinical trials (Systemic Lupus Erythematous and Rheumatoid Arthritis).

Clinical Program Manager - Senior Clinical Operations Consultant

Jazz Pharmaceuticals

Project contributions supported Vyxeos®, Rylaze™, Zepzelca™ collaborative (CO) and Investigator-Sponsored Research (ISR) clinical trials.

Zogenix, Inc.

Project contributions supported FINTEPLA® (approved 25-June-2020) for the treatment of Dravet Syndrome (DS), Lennox-Gastaut Syndrome (LGS) (approved 28-Mar-2022), and advancement of CDKL5 Deficiency Disorder (CDD) clinical trials.

Zogenix, Inc. (Nasdaq: ZGNX) was acquired by UCB (Euronext: UCB) on 19January2022 for $1.9 Billion USD.

Apollomics

Project contributions supported advancement of APL-101, a novel, orally administered, selective c-MET inhibitor.

taplio

The Battle

Sam Khairi

Bobby Asem, MBA

Followers

Posts

Engagements

Likes

Ready to grow your LinkedIn presence?